Descargalo en: 
lunes, 17 de octubre de 2011
sábado, 8 de octubre de 2011
Traumatic Diaphragmatic Hernia
N Engl J Med 2011; 365:e30October 6, 2011
Edoardo Picetti, M.D.
Mario Mergoni, M.D.Servizio Anestesia e Rianimazione, Parma, Italy
A 6-year-old boy presented to our hospital after several hours of vomiting and dyspnea. He had been in a motor vehicle accident 6 months earlier and sustained a seatbelt injury that necessitated surgical repair of a right diaphragmatic hernia, accessed through the right thorax. A postoperative anteroposterior plain radiograph (Panel A) showed a raised left hemidiaphragm (arrow) and a left chest tube (arrowhead) that had been placed earlier to drain a left hemothorax. The boy was discharged from the hospital after recovering from his injuries. At the time of the current presentation, physical examination revealed no breath sounds over the left hemithorax. Anteroposterior plain radiography of the chest (Panel B) showed a large, gas-filled structure in the left hemithorax (long arrow), near-complete collapse of the left lung (short arrow), and a marked rightward shift of the mediastinum (arrowhead). The left hemidiaphragm could not be clearly seen. After the administration of contrast material through a nasogastric tube, repeat chest radiography was performed and confirmed that the stomach lay within the left hemithorax (Panel C). The patient had a left posterolateral diaphragmatic rupture and underwent emergency surgery, during which the stomach, spleen, left kidney, and part of the transverse colon were repositioned within the abdomen and the rupture repaired. A postoperative chest radiograph showed reexpansion of the left lung (Panel D). The patient had a smooth recovery and was discharged home 10 days after the surgery.
Bronquitis aguda, una patología muy frecuente
Una breve revisión sobre los aspectos mas importantes de esta enfermedad.
Descárgela aqui:http://www.4shared.com/file/iRhDUqE_/Bronquitis_aguda.html
Original Article
October 6, 2011 | D. Slamon and Others
Trastuzumab added to a nonanthracycline regimen to treat HER2-positive breast cancer resulted in rates of disease-free and overall survival that were similar to those for an anthracycline-containing regimen, with lower rates of cardiac toxicity and secondary leukemia.
Suscribirse a:
Entradas (Atom)